TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
GEBE Medicinsk och Bioteknisk Konsult AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
330
|
205
|
64 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
1,865
|
-31
|
-381 |
EBITDA |
1,806
|
-13
|
-362 |
Total assets |
3,972
|
1,949
|
2,296 |
Current assets |
3,972
|
462
|
742 |
Current liabilities |
380
|
26
|
104 |
Equity capital |
3,531
|
1,880
|
2,153 |
- share capital |
101
|
95
|
98 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
88.9%
|
96.5%
|
93.8% |
Turnover per employee |
165
|
102
|
32 |
Profit as a percentage of turnover |
565.2%
|
-15.1%
|
-595.3% |
Return on assets (ROA) |
47.0%
|
-1.6%
|
-16.6% |
Current ratio |
1045.3%
|
1776.9%
|
713.5% |
Return on equity (ROE) |
52.8%
|
-1.6%
|
-17.7% |
Change turnover |
110
|
143
|
15 |
Change turnover % |
50%
|
229%
|
29% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.